Ann Fitzmaurice
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ann Fitzmaurice has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Wendy J. Graham
Immpact, School of Medicine and Dentistry, University of Aberdeen, Aberdeen, UK
2 shared publications - Adjima Gbangou
Direction des Etudes et de la Planification, Ministère de la Santé, Ouagadougou, Burkina Faso
1 shared publication - Cecile Tamini
Immpact, Centre Muraz, Bobo-Dioulasso, Burkina Faso
1 shared publication - Edward Fottrell
Institute for Global Health, University College London, London, UK
1 shared publication - Issiaka Sombié
Département de Santé Publique, Centre Muraz, 01 BP 390 Bobo-Dioulasso, Burkina Faso
1 shared publication - Janet Tornui
Immpact, Noguchi Memorial Institute for Medical Research, Accra, Ghana
1 shared publication
Latest Publications
- Open Access
- 24 November 2010
- Published by Springer Nature in BMC Public Health
- Vol. 10 (1) , 727
The impact of economic recession on maternal and infant mortality: lessons from history
The effect of the recent world recession on population health has featured heavily in recent international meetings. Maternal health is a particular concern given that many countries were already falling short of their MDG targets for 2015.
- 24 November 2010
- Published by Springer Nature in BMC Public Health
- Vol. 10 (1) , 727
Open AccessThe impact of economic recession on maternal and infant mortality: lessons from history
The effect of the recent world recession on population health has featured heavily in recent international meetings. Maternal health is a particular concern given that many countries were already falling short of their MDG targets for 2015.
- Open Access
- 8 February 2007
- Published by Springer Nature in Population Health Metrics
- Vol. 5 (1) , 1
Revealing the burden of maternal mortality: a probabilistic model for determining pregnancy-related causes of death from verbal autopsies
Background: Substantial reductions in maternal mortality are called for in Millennium Development Goal 5 (MDG-5), thus assuming that maternal mortality is measurable. A key difficulty is attributing causes of death for the many women who die unaided in developing countries. Verbal autopsy (VA) can elicit circumstances of death, but data need to be interpreted reliably and consistently to serve as global indicators. Recent developments in probabilistic modelling of VA interpretation are adapted and assessed here for the specific circumstances of pregnancy-related death. Methods: A preliminary version of the InterVA-M probabilistic VA interpretation model was developed and refined with adult female VA data from several sources, and then assessed against 258 additional VA interviews from Burkina Faso. Likely causes of death produced by the model were compared with causes previously determined by local physicians. Distinction was made between free-text and closed-question data in the VA interviews, to assess the added value of free-text material on the model's output. Results: Following rationalisation between the model and physician interpretations, cause-specific mortality fractions were broadly similar. Case-by-case agreement between the model and any of the reviewing physicians reached approximately 60%, rising to approximately 80% when cases with a discrepancy were reviewed by an additional physician. Cardiovascular disease and malaria showed the largest differences between the methods, and the attribution of infections related to pregnancy also varied. The model estimated 30% of deaths to be pregnancy-related, of which half were due to direct causes. Data derived from free-text made no appreciable difference. Conclusion: InterVA-M represents a potentially valuable new tool for measuring maternal mortality in an efficient, consistent and standardised way. Further development, refinement and validation are planned. It could become a routine tool in research and service settings where levels and changes in pregnancy-related deaths need to be measured, for example in assessing progress towards MDG-5.
- 8 February 2007
- Published by Springer Nature in Population Health Metrics
- Vol. 5 (1) , 1
Open AccessRevealing the burden of maternal mortality: a probabilistic model for determining pregnancy-related causes of death from verbal autopsies
Background: Substantial reductions in maternal mortality are called for in Millennium Development Goal 5 (MDG-5), thus assuming that maternal mortality is measurable. A key difficulty is attributing causes of death for the many women who die unaided in developing countries. Verbal autopsy (VA) can elicit circumstances of death, but data need to be interpreted reliably and consistently to serve as global indicators. Recent developments in probabilistic modelling of VA interpretation are adapted and assessed here for the specific circumstances of pregnancy-related death. Methods: A preliminary version of the InterVA-M probabilistic VA interpretation model was developed and refined with adult female VA data from several sources, and then assessed against 258 additional VA interviews from Burkina Faso. Likely causes of death produced by the model were compared with causes previously determined by local physicians. Distinction was made between free-text and closed-question data in the VA interviews, to assess the added value of free-text material on the model's output. Results: Following rationalisation between the model and physician interpretations, cause-specific mortality fractions were broadly similar. Case-by-case agreement between the model and any of the reviewing physicians reached approximately 60%, rising to approximately 80% when cases with a discrepancy were reviewed by an additional physician. Cardiovascular disease and malaria showed the largest differences between the methods, and the attribution of infections related to pregnancy also varied. The model estimated 30% of deaths to be pregnancy-related, of which half were due to direct causes. Data derived from free-text made no appreciable difference. Conclusion: InterVA-M represents a potentially valuable new tool for measuring maternal mortality in an efficient, consistent and standardised way. Further development, refinement and validation are planned. It could become a routine tool in research and service settings where levels and changes in pregnancy-related deaths need to be measured, for example in assessing progress towards MDG-5.